VCEL - Vericel Corp
34.96
0.570 1.630%
Share volume: 536,235
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$34.39
0.57
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-01-2024 | 11-07-2024 | 02-27-2025 | 05-08-2025 | 07-31-2025 | 11-06-2025 | 02-26-2026 | |
| Total revenue | 51.281 M | 52.662 M | 57.905 M | 75.376 M | 52.598 M | 63.240 M | 67.503 M | 92.918 M | |
| Cost of revenue | 15.927 M | 16.061 M | 16.252 M | 16.877 M | 16.325 M | 16.627 M | 17.918 M | 19.790 M | |
| Gross profit | 35.354 M | 36.601 M | 41.653 M | 58.499 M | 36.273 M | 46.613 M | 49.585 M | 73.128 M | |
| 3.53% | 13.80% | 40.44% | -37.99% | 28.51% | 6.38% | 47.48% | |||
| Operating expenses | 40.818 M | 42.632 M | 44.118 M | 40.020 M | 49.065 M | 48.642 M | 46.135 M | 50.713 M | |
| Selling general and admin | 34.400 M | 35.269 M | 38.025 M | 35.097 M | 41.804 M | 41.911 M | 39.817 M | 43.460 M | |
| Research and development | 6.418 M | 7.363 M | 6.093 M | 4.923 M | 7.261 M | 6.731 M | 6.318 M | 7.253 M | |
| Total expenses | 56.745 M | 58.693 M | 44.118 M | 40.020 M | 49.065 M | 48.642 M | 46.135 M | 50.713 M | |
| 3.43% | -24.83% | -9.29% | 22.60% | -0.86% | -5.15% | 9.92% | |||
| Operating income | -5.464 M | -6.031 M | -2.465 M | 18.479 M | -12.792 M | -2.029 M | 3.450 M | 22.415 M | |
| Ebit | -5.464 M | -6.031 M | -2.325 M | 18.549 M | -12.750 M | -2.053 M | 3.424 M | 22.379 M | |
| Pretax income | -3.862 M | -4.682 M | -901.000 K | 19.955 M | -11.246 M | -553.000 K | 5.074 M | 24.102 M | |
| 21.23% | -80.76% | -2,314.76% | -156.36% | -95.08% | -1,017.54% | 375.01% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -3.862 M | -4.682 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| -21.23% | 100.00% | ||||||||
| Net income | -3.862 M | -4.682 M | -901.000 K | 19.807 M | -11.246 M | -553.000 K | 5.074 M | 23.243 M | |
| -21.23% | 80.76% | 2,298.34% | -156.78% | 95.08% | 1,017.54% | 358.08% |